S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial
OTCMKTS:NWBO

Northwest Biotherapeutics (NWBO) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free NWBO Stock Alerts
$0.50
-0.02 (-3.83%)
(As of 04/15/2024 ET)
Compare
Today's Range
$0.50
▼
$0.54
50-Day Range
$0.48
▼
$0.61
52-Week Range
$0.40
▼
$1.09
Volume
1.07 million shs
Average Volume
1.82 million shs
Market Capitalization
$602.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest
NWBO stock logo

About Northwest Biotherapeutics Stock (OTCMKTS:NWBO)

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

NWBO Stock Price History

NWBO Stock News Headlines

April 16, 2024 | americanbankingnews.com
Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average of $0.67
March 21, 2024 | prnewswire.com
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
April 16, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
March 2, 2024 | ft.com
‘Spoofing’ case might draw back curtain on high-speed trading firms
February 29, 2024 | uk.finance.yahoo.com
Northwest Biotherapeutics, Inc. (NWBO)
February 23, 2024 | benzinga.com
Northwest Biotherapeutics Stock (OTC:NWBO), Short Interest Report
February 7, 2024 | finance.yahoo.com
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
December 22, 2023 | msn.com
Northwest Biotherapeutics submits marketing application to UK MHRA for DCVax-L
April 16, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
December 21, 2023 | finanznachrichten.de
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax-L For Glioblastoma
December 21, 2023 | finance.yahoo.com
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
November 22, 2023 | finance.yahoo.com
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
October 31, 2023 | morningstar.com
Northwest Biotherapeutics Inc NWBO
October 14, 2023 | msn.com
Northwest Bio: Another Small Filing Delay
October 13, 2023 | seekingalpha.com
NW Bio dips on announcing delay in submission of marketing application for DCVax
October 13, 2023 | marketwatch.com
Northwest Biotherapeutics Shares Slide on Application Delay
October 13, 2023 | finance.yahoo.com
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
September 12, 2023 | finance.yahoo.com
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board
August 17, 2023 | msn.com
Northwest Bio: Is There Ever Going To Be A Right Time?
August 6, 2023 | usnews.com
Northwest Missouri State University
August 4, 2023 | health.usnews.com
Northwest Hospital
July 15, 2023 | thestreet.com
Why Northwest Bio Is Shunned by Savvy Health Care Investors
June 19, 2023 | pnj.com
Three rounds of severe weather expected over the next 24 hours for Northwest Florida
June 13, 2023 | health.usnews.com
HCA Houston Healthcare Northwest
May 27, 2023 | finance.yahoo.com
NWBO - Northwest Biotherapeutics, Inc.
May 9, 2023 | thestreet.com
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
April 13, 2023 | health.usnews.com
Northwest Medical Center-Tucson
See More Headlines
Receive NWBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/16/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:NWBO
Previous Symbol
NASDAQ:NWBO
CUSIP
N/A
CIK
1072379
Web
www.nwbio.com
Phone
(240) 497-9024
Fax
240-627-4121
Employees
25
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-62,600,000.00
Net Margins
-3,240.11%
Pretax Margin
-3,240.11%
Return on Equity
N/A
Return on Assets
-207.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.09
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$1.93 million
Price / Sales
312.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-8.37

Miscellaneous

Outstanding Shares
1,201,100,000
Free Float
1,034,147,000
Market Cap
$602.95 million
Optionable
Not Optionable
Beta
-0.68
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Ms. Linda F. Powers J.D. (Age 68)
    Chairperson, CEO, President, CFO & Chief Accounting Officer
    Comp: $1.1M
  • Dr. Alton L. Boynton Ph.D. (Age 79)
    Founder, Chief Scientific Officer, Secretary & Director
    Comp: $450k
  • Dr. Marnix L. Bosch M.B.A. (Age 65)
    Ph.D., Chief Technical Officer
    Comp: $597.5k
  • Mr. Leslie J. Goldman (Age 79)
    Senior VP & General Counsel
    Comp: $825k
  • Ms. Jean M. Davis (Age 52)
    Chief Information Officer
    Comp: $258.78k
  • Mr. David Innes
    Vice President of Investor Relations
  • Mr. Pankaj R. Shah C.A.
    CPA, Financial Controller

Key Competitors

View All Competitors

NWBO Stock Analysis - Frequently Asked Questions

How have NWBO shares performed in 2024?

Northwest Biotherapeutics' stock was trading at $0.7010 at the beginning of 2024. Since then, NWBO shares have decreased by 28.4% and is now trading at $0.5020.
View the best growth stocks for 2024 here.

When is Northwest Biotherapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our NWBO earnings forecast.

How were Northwest Biotherapeutics' earnings last quarter?

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) posted its quarterly earnings results on Tuesday, March, 5th. The biotechnology company reported ($0.02) earnings per share for the quarter. The biotechnology company had revenue of $0.45 million for the quarter.

What other stocks do shareholders of Northwest Biotherapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Northwest Biotherapeutics investors own include Clearside Biomedical (CLSD), Ocular Therapeutix (OCUL), Melinta Therapeutics (MLNT), (ZLTQ) (ZLTQ), Avid Bioservices (CDMO), Idera Pharmaceuticals (IDRA), Amarin (AMRN), Inovio Pharmaceuticals (INO) and MEI Pharma (MEIP).

How do I buy shares of Northwest Biotherapeutics?

Shares of NWBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NWBO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing